Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Determining the Unit Cost of Services: A Guide for Estimating the Cost of Services Funded by the Ryan White CARE Act of 1990
Guide developed in 1992 to help Ryan White CARE Act agencies estimate the average unit cost of services.Resource updated 09/19/2023
-
An Assessment of A Pilot Peer Navigation Program Linking HIV Positive Clients of Harm Reduction Services With Ryan White Clinical Service Providers
This is an Evaluation Report of a pilot peer navigation program funded by HRSA/HAB. It is a part of the Minority AIDS Initiative. It trained patient navigators at harm reduction sites in New Jersey and New Mexico.
Resource updated 11/25/2019
-
Making a Mark: Demonstrating Health Impacts among RWHAP Recipients Utilizing National Quality Center (NQC)
Results from the HIV Cross‐Part Care Continuum Collaborative (H4C) to affect measurable improvements in broad geographic regions utilizing the HIV Care Continuum.
Resource updated 09/14/2023
-
Billing and Coding for HIV Care
Team roles and responsibilities as well as strategies for billing and coding for HIV care.Resource updated 08/28/2023
-
Blueprints for Success: A Virtual Conference for HIV Providers
Sessions on building the organizational sustainability of AIDS Service Organizations and community based organizations.Resource updated 02/04/2022
-
ASOs, CBOs and Pharmacists: Untapped Partnerships for Success
Review of how HIV care can be enhanced when agencies establish partnerships with pharmacists.Resource updated 08/28/2023
-
Addressing Fiscal Barriers: Payment Delays and Organizational Cash Flow
Insights for ASOs and CBOs on how to deal with payment delays and organizational cash flow so as to minimize the impact of these challenges on your organization’s short- and long-term sustainability.Resource updated 08/28/2023
-
Rapid ART: An Essential Strategy to End the HIV Epidemic
Insights for entities seeking to create or strengthen rapid ART.Resource updated 03/15/2023
-
Intervention Cost Calculator
Excel calculator to facilitate cost comparisons and selection of interventions of interest based on available resources. Disponible en Español.Resource updated 09/19/2023
-
Adolescent Viral Load Suppression: Challenges and Success Stories
Resource (Conference Presentation) updated 09/14/2023
-
Average Time to Initiation of Antiretroviral Therapy - Newly Diagnosed HIV Patients - University of Utah
Resource (Conference Presentation) updated 09/14/2023
-
Rapid Access of Initial HIV Appointment and ART Prescription
Resource (Conference Presentation) updated 09/14/2023
-
Rapid Access for HIV Care and Prevention in a Center for Youth
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
-
Proactive Clinic-Based Substance Abuse Screening and Treatment: Helping to Advance in New Directions (Helping HAND)
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
-
Test-and-Treat Protocol in a Rural State To Decrease Time to Undetectable Viral Load
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
-
Subrecipient and Service Provider Monitoring Practices in Texas
Sound monitoring practices require collaboration across an organization to implement strong financial and program management systems. The Texas Ryan White Part B program and fiscal monitoring units have developed robust processes and tools to share with other Ryan White recipients.
Learning Objectives
- Improving fiscal and program collaboration.
- Developing monitoring tools.
- Incorporating data analytics into compliance monitoring.
Resource (Conference Presentation) updated 09/14/2023
-
Innovative Automation in Data Management, Claims Processing, and Electronic Billing to Save Time and Costs!
This session will discuss the impact of innovative automation on fiscal management, client consents, data sharing, and Ryan White eligibility determination across the subrecipients of the EMA, saving time, effort, and costs leading to improved service delivery, outcomes, and program workflow.
Resource (Conference Presentation) updated 09/14/2023
-
Identifying, Tracking, and Reporting Program Income Generated through the 340B Program and Other Sources
Ryan White Part B fiscal monitors in Texas developed processes and tools to identify, track, and report program income generated through the 340B program and other sources of revenue. Tools include a spending plan template and an allocation worksheet, which will be shared with other RWHAP recipients in this workshop.
Learning Objectives
- Identify sources and allowable uses of program income.
- Develop monitoring tools for program income.
- Incorporate data analytics into compliance monitoring.
Resource (Conference Presentation) updated 09/14/2023
-
Long-Acting ART HIV Treatment Regimens: Key Behavioral Considerations for Stakeholders
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023